Otsuka Podcast-logo

Otsuka Podcast

Business & Economics Podcasts >

More Information


Volume 105: Otsuka Leader in U.S. Honored by Gives Keynote on Digital Medicine Era

See the full story with pictures at: Dr. William H. Carson, president and chief executive officer of Otsuka Pharmaceutical Development & Commercialization in the U.S., was lauded as one of 2018’s Top Blacks in Healthcare honorees selected by at their 5th annual gala on April 26, 2018. The event, presented by in conjunction with The George Washington University Milken Institute...


Volume 104: Daiya, North America’s Leading Maker of Plant-Based Comfort Foods

Daiya, North America’s Leading Maker of Plant-Based Comfort Foods Daiya Foods was founded in Vancouver, Canada in 2008 with a simple belief that plant-based living was better for people’s health, better for the planet and better for animal welfare. It all started with the founders, Greg Blake and Andre Kroecher, trying to make plant-based cheese at home in the kitchen with a blender and a pot on the stove. Their perseverance paid off and Daiya Cheddar Style & Mozzarella Style Shreds...


Volume 103: A Tireless Patient Advocate Against PKD Rejoices on Drug Approval

See the full story with pictures at: Bill Brazell was ecstatic on April 24 upon reading a decision he has long advocated for and awaited: U.S. regulatory approval of Otsuka’s tolvaptan for use in slowing the progression of ADPKD (autosomal dominant polycystic kidney disease) in patients at risk of rapid progression. ADPKD is a progressive, inherited condition in which cysts proliferate in the kidneys, often...


Volume 102: Astex’s Harren Jhoti Receives Highest Accolade from the UK BioIndustry Association

See the full story with pictures at: On January 25, the BioIndustry Association (BIA) honoured Dr. Harren Jhoti, president & CEO of Astex, UK (an independent subsidiary of Otsuka Pharmaceutical) with a Lifetime Achievement Award. The Award was presented by Dr. Jane Osbourn (BIA Chair) at a dinner attended by 700 professionals from the UK life sciences sector. Dr. Osbourne commented, “Harren’s contribution to the UK...


Vol. 101: Otsuka and NASCAR Race Together to Champion Mental Health

See the full story with pictures at: Otsuka America Pharmaceutical, Inc. and the National Association for Stock Car Auto Racing (NASCAR) team Chip Ganassi Racing (CGR) joined together to mark Mental Health Awareness Week at Charlotte, North Carolina on October 7th and 8th, 2017. In the US, NASCAR is second only to American Football as the most popular sport in the country in terms of both television viewers and live...


Vol. 100: Developing Heroes On and Off the Futsal Pitch

Sports are good for the body, mind and spirit. Participating in sports boosts self-esteem, team-work and leadership skills, and provides a channel for young people to relieve stress. Five years ago, the Korean Ministry of Education launched an initiative to encourage sports club activities in schools. In support of this initiative, Donga Otsuka, an Otsuka affiliate and manufacturer of POCARI SWEAT for the Korean market, launched a tournament intended to help young people learn the twin...


Vol. 99: Otsuka Recognized at the Polycystic Kidney Disease Foundation Gratitude Event

See the full story with pictures at On April 22, 2017, the Polycystic Kidney Disease (PKD) Foundation honored Otsuka Pharmaceutical for our long-standing and successful commitment to develop an innovative, first-in-class drug treatment for autosomal dominant polycystic kidney disease (ADPKD) and for its collaboration with the foundation. “Working together with basic science funded by PKD Foundation and the...


Vol. 98: Clinical Access Program for MDR-TB Medicine Launched in South Africa

See the full story with pictures at On World TB Day, March 24th 2017, Otsuka Pharmaceutical in cooperation with South Africa’s Ministry of Health and a non-governmental organization called Right to Care, officially launched DCAP, a clinical access program for delamanid (DeltybaTM), a medicine developed by Otsuka for the treatment of pulmonary multidrug-resistant tuberculosis (MDR-TB). The event, organized by...


Vol. 97: Astex employees get walking for blood cancer charity

See the full story with pictures at Every year since 2000, Astex employees and their families have taken part in the Light The Night of East Bay event in Walnut Creek in Northern California to raise much needed funds and awareness to support the Leukemia and Lymphoma Society (LLS). The LLS, founded in 1949, is the largest voluntary organization in the US dedicated to research, finding cures and ensuring access to treatment for blood cancer...


Vol. 96: Nutrition & Santé wins top national award for sustainability efforts

See the full story with pictures at Otsuka Group member Nutrition & Santé, a leading manufacturer of dietetic products including slimming and sports foods, won the 2017 Inaugural Grand Prix Award from the French National Association of Food Industries (ANIA) and EY *1 at an award ceremony held on January 18th. The prize rewards French food industry companies for their growth in France or overseas, for job creation, and for their commitment...


Vol. 95: Opening of the RIKEN CDB-Otsuka Pharmaceutical Collaboration Center

See the full story with pictures at In September of 2016, Otsuka Pharmaceutical and RIKEN opened the RIKEN CDB-Otsuka Pharmaceutical Collaboration Center (COCC) inside the RIKEN Center for Developmental Biology (RIKEN CDB), which is located in the city of Kobe. The COCC will be involved in collaborative developmental biology and regenerative medicine research projects with the goal of investigating disease mechanisms and discovering...


Vol. 94: Otsuka Develops a New Pill Dispenser with NEC Using IoT Technologies

Read the full story with photos at: Otsuka Pharmaceutical and NEC Corporation have partnered to jointly develop a smart medicine container that will help ensure that patients do not forget to take their daily dose of anti-stroke medication. Otsuka has experience with patients who have suffered one or more strokes through its involvement in the research, development and marketing of blood-thinning drugs, and NEC has many years of experience...


Vol. 92: Educational awareness tool for nerve & mental diseases wins at Cannes

Watch the video of this award-winning tool at: A portion of our activities dedicated to reducing bias among the general public about nerve and mental diseases has won the Bronze for the Pharma category of Lions Health at the 63rd Cannes Lions International Festival of Creativity, the most prestigious international award for creativity. The activity which was awarded the Bronze uses the booklet “Connect Pen...


Vol. 91: A New Partner for Global Health Innovative Technology (GHIT) Fund

Read the full story with photos at Otsuka Pharmaceutical participated in the Global Health Innovative Technology (GHIT) Fund as an associate partner on June 7th, 2016. GHIT Fund was established in April 2013 as the world’s first product development fund specialized in Global Health through partnerships with the public (i.e. Japanese government), private, and civil sectors (Bill & Melinda Gates Foundation,...


Vol. 90: Otsuka Hosted First-Ever Documentary About PseudoBulbar Affect

Read the full story with photos at: Otsuka America Pharmaceutical, Inc. hosted a special screening of the first-ever documentary film on living with PseudoBulbar affect (PBA), “Beyond Laughter and Tears, A Journey of Hope”, during the American Psychiatric Association (APA) annual meeting in Atlanta on May 16, 2016. The documentary was created by Avanir Pharmaceuticals, Inc., an Otsuka subsidiary, in order...


Vol. 89: US Otsuka Pharmaceutical Colleague Honored for Leadership

See the full story with photos at Mr. Bob Oliver, president & CEO of Otsuka America Pharmaceutical, Inc., (OAPI), served as the keynote speaker and honoree at the 3rd Annual Top Blacks in Healthcare Awards Gala held in spring this year in Baltimore. The Gala, hosted by, a leading online health destination for African Americans, and the Johns Hopkins Center for Health Disparities Solutions,...


Vol. 88: Minister of Education, Culture, Sports, Science and Technology Honored Otsuka 2 Awards

Read the original article with photos at: The Minister of Education, Culture, Sports, Science and Technology awarded Otsuka Pharmaceutical Co., Ltd. two commendations for Science and Technology in Tokyo, Japan. One of the prizes for Science and Technology, in the Development Category, was for the research and development of delamanid. It is an effective treatment for multi-drug resistant tuberculosis. The...


Vol. 87: Delamanid Available To 100+ Countries Through an Innovative Partnership

Read the full article with photos at Otsuka and the Stop TB Partnership’s Global Drug Facility (GDF) announced a worldwide access plan for delamanid, one of only two medications approved to treat multidrug-resistant tuberculosis (MDR-TB) in the last 40 years. The GDF is the largest supplier of quality assured TB treatments in the public sector, which gives it a unique position to catalyse uptake and...


Vol. 77: The Sixth Annual Sistine Kabuki With a Modern Twist of Technology

Read the full article with photos at The Otsuka Museum of Art hosted the sixth Sistine Kabuki production – Yuriwaka Daijin: Ulysses – for 3 days, beginning on February 20, with two performances each day. As has been the case in past years, tickets sold out almost as soon as they went on sale. The performances were attended by 2800 persons from across Japan. Incorporating Technology in Kabuki The stage for this year's...